Comparison of the efficacy, safety and tolerability of policosanol and atorvastatin in patients with type II hypercholesterolemia

Gladys Casta?o; José Illnait; Julio Fernández; Lilia Fernández; Meylin Mesa; Rosa Más; Sarahí Mendoza

首页> 外文期刊>Revista CENIC Ciencias Biologicas >Comparison of the efficacy, safety and tolerability of policosanol and atorvastatin in patients with type II hypercholesterolemia

【24h】

Comparison of the efficacy, safety and tolerability of policosanol and atorvastatin in patients with type II hypercholesterolemia

机译：policosanol和阿托伐他汀在II型高胆固醇血症患者中的疗效，安全性和耐受性比较

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Hypercholesterolemia is a major coronary risk factor. The main goal of dyslipidemia control in is to lower elevated LDL-C levels. Policosanol is a cholestero...

机译：高胆固醇血症是主要的冠心病危险因素。控制血脂异常的主要目标是降低升高的LDL-C水平。二十烷醇是一种胆固醇...

著录项

来源
《Revista CENIC Ciencias Biologicas 》 |2005年第3期| 共页
作者
Gladys Casta?o; José Illnait; Julio Fernández; Lilia Fernández; Meylin Mesa; Rosa Más; Sarahí Mendoza;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类普通生物学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Comparison of the efficacy, safety and tolerability of original policosanol versus other mixtures of higher aliphatic primary alcohols in patients with type II hypercholesterolemia. [J] . Castano G, Fernandez L, Mas R, International Journal of Clinical Pharmacology Research . 2002 ,第2期

机译：原始波多固醇与其他高级脂肪族伯醇混合物在II型高胆固醇血症患者中的疗效，安全性和耐受性比较。
2. Comparative efficacy, safety and tolerability of policosanol versus statins in patients with type II hypercholesterolemia: emphasis on muscle function indicators [J] . Gladys Casta?o, José Illnait, Julio C. Fernández, Revista CENIC Ciencias Biologicas . 2003 ,第3期

机译：泊可固醇与他汀类药物在II型高胆固醇血症患者中的疗效，安全性和耐受性比较：重点是肌肉功能指标
3. Comparison of the Efficacy and Tolerability of Policosanol with Atorvastatin in Elderly Patients with Type II Hypercholesterolaemia. [J] . Castano G, Mas R, Fernandez L, Drugs and aging . 2003 ,第2期

机译：泊可沙醇与阿托伐他汀在II型高胆固醇血症老年患者中的疗效和耐受性比较。
4. Therapy of Patients with Chronic Immune Thrombocytopenic Purpura (ITP): Efficacy, Tolerability, and Safety of a New Nanofiltered Intravenous Immunoglobulin [C] . H.-H. Wolf, S. Davies, G. Smith, European Haematology Association . 2002

机译：慢性免疫血小板减少症患者的治疗患者（ITP）：一种新的纳米过滤静脉内免疫球蛋白的疗效，耐受性和安全性
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR) [O] . Michael B Clearfield, John Amerena, Jean-Pierre Bassand, 2006

机译：瑞舒伐他汀10 mg和阿托伐他汀20 mg在高胆固醇血症高危患者中的疗效和安全性比较–前瞻性研究评估低剂量他汀类药物阿托伐他汀和瑞舒伐他汀（PULSAR）的使用
7. Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR) [O] . García Hugo, Bassand Jean-Pierre, Amerena John, 2006

机译：瑞舒伐他汀10 mg和阿托伐他汀20 mg在高胆固醇血症高危患者中的疗效和安全性比较–前瞻性研究评估低剂量他汀类药物阿托伐他汀和瑞舒伐他汀（PULSAR）的使用

Comparison of the efficacy, safety and tolerability of policosanol and atorvastatin in patients with type II hypercholesterolemia

摘要

著录项

相似文献

相关主题

期刊订阅